Indocyanine green loaded liposome nanocarriers for photodynamic therapy using human triple negative breast cancer cells

被引:59
|
作者
Shemesh, Colby S. [1 ]
Hardy, Claire W. [2 ]
Yu, David S. [2 ]
Fernandez, Brian [1 ]
Zhang, Hailing [1 ]
机构
[1] Mercer Univ, Coll Pharm, Dept Pharmaceut Sci, Drug Delivery Lab, Atlanta, GA 30341 USA
[2] Emory Univ, Sch Med, Dept Radiat Oncol, Atlanta, GA 30322 USA
关键词
Indocyanine green (ICG); Photodynamic therapy (PDT); Thermosensitive liposome; Triple negative breast cancer (TNBC); DNA damage; DNA-DAMAGE; GAMMA-H2AX; MITOCHONDRIA; APOPTOSIS; DELIVERY; REPAIR;
D O I
10.1016/j.pdpdt.2014.02.001
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The goal of the current research is to evaluate the potential of photodynamic therapy (PDT) in the treatment of triple negative breast cancer (TNBC) with the development of a theranostic thermosensitive liposome platform to deliver indocyanine green (ICG) as the near-infrared (NIR) photosensitizer excited by an 808 nm diode laser. Methods: In the PDT protocol, an optimized thermosensitive liposome formulation is investigated to formulate ICG as the photosensitizer, which is exited by laser light at the wavelength of 808 nm delivered by a fiber-coupled laser system. ICG in both free solution and thermosensitive liposomal formulation were evaluated as the NIR photosensitizer and compared in the PDT treatment on a panel of triple negative breast cancer cell lines along with the nontumorigenic mammary epithelial cell line MCF-10A. In addition to cytotoxicity, and clonogenic survival assessment, the role of DNA double strand break damage was evaluated. Results: Both MTT and clonogenic assays revealed that PDT using ICG inhibited the growth of several TNBC cell lines as well as the non-tumorigenic human breast epithelial cell line MCF-10A; and the liposomal formulation of ICG did not compromise the in vitro treatment potency, though free ICG performed slightly more effective in certain cell lines, but was not statistically significant. Cell viability was dose dependent in regards to ICG concentration and irradiation energy. Interestingly, PDT using the described protocol was more potent to inhibit the growth of MDA-MB-468 and HCC-1806 cells, coinciding with the observation that these cells are more sensitive toward DNA damaging agents. In comparison, cell lines HCC-70, BT-549, and MCF-10A were found to have less of an inhibitory effect. Furthermore, substantial DNA double strand breaks (DSBs) were observed 30 min after the PDT treatment via a gamma-H2AX staining assay. PDT induced DNA damage has the potential to lead to mutagenicity, which may have various responses depending on the repair capabilities of the cells. Conclusion: Our results suggest that PDT using indocyanine green loaded liposomes were effective in inhibiting tumor cell growth to varying extents with higher responses observed for MDA-MB-468 and HCC-1806 cells. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:193 / 203
页数:11
相关论文
共 50 条
  • [31] Effect of platelet exosomes loaded with doxorubicin as a targeted therapy on triple-negative breast cancer cells
    Dilara Uslu
    Burcin Irem Abas
    Gulen Melike Demirbolat
    Ozge Cevik
    Molecular Diversity, 2024, 28 : 449 - 460
  • [32] Synergic anti-tumor effects of photodynamic therapy and resveratrol on triple-negative breast cancer cells
    Ghazizadeh, Masta
    Khorsandi, Khatereh
    Najafi, SMahmoud A.
    PHOTOCHEMICAL & PHOTOBIOLOGICAL SCIENCES, 2025, 24 (03) : 451 - 465
  • [33] Evaluating Nanoshells and a Potent Biladiene Photosensitizer for Dual Photothermal and Photodynamic Therapy of Triple Negative Breast Cancer Cells
    Riley, Rachel S.
    O'Sullivan, Rachel K.
    Potocny, Andrea M.
    Rosenthal, Joel
    Day, Emily S.
    NANOMATERIALS, 2018, 8 (09)
  • [34] PHOTODYNAMIC THERAPY OF SUBCUTANEOUS AND INTRAOCULAR TUMORS USING INDOCYANINE GREEN
    WARN, AA
    NORDQUIST, RE
    CHEN, W
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1994, 35 (04) : 1924 - 1924
  • [35] Advancements in Polymeric Nanocarriers to Mediate Targeted Therapy against Triple-Negative Breast Cancer
    Fatima, Mahak
    Sheikh, Afsana
    Abourehab, Mohammed A. S.
    Kesharwani, Prashant
    PHARMACEUTICS, 2022, 14 (11)
  • [36] Photodynamic acidification therapy to reduce triple negative breast cancer growth in vivo.
    Kadri, Nuha Buchanan
    Gdovin, Matthew
    Alyassin, Nizar
    Avila, Justin
    Cruz, Aryana
    Cruz, Louis
    Holliday, Steve
    Jordan, Zachary
    Ruiz, Cameron
    Watts, Jennifer
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [37] Photoactive Parietin-loaded nanocarriers as an efficient therapeutic platform against triple-negative breast cancer
    Ayoub, Abdallah M.
    Abdelsalam, Ahmed M.
    Schulze, Jan
    Amin, Muhammad U.
    Engelhardt, Konrad
    Wojcik, Matthias
    Librizzi, Damiano
    Yousefi, Behrooz H.
    Nasrullah, Usman
    Pfeilschifter, Josef
    Bakowsky, Udo
    Preis, Eduard
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2023, 643
  • [38] Emerging indocyanine green-integrated nanocarriers for multimodal cancer therapy: a review
    Gowsalya, Karunanidhi
    Yasothamani, Vellingiri
    Vivek, Raju
    NANOSCALE ADVANCES, 2021, 3 (12): : 3332 - 3352
  • [39] Recent Advances in Targeted Nanocarriers for the Management of Triple Negative Breast Cancer
    Pradhan, Rajesh
    Dey, Anuradha
    Taliyan, Rajeev
    Puri, Anu
    Kharavtekar, Sanskruti
    Dubey, Sunil Kumar
    PHARMACEUTICS, 2023, 15 (01)
  • [40] "Stealth" dendrimers with encapsulation of indocyanine green for photothermal and photodynamic therapy of cancer
    Cui, Tianming
    Li, Shukai
    Chen, Shengfu
    Liang, Ying
    Sun, Haotian
    Wang, Longgang
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2021, 600